Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2020-07-13 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Bodal Chemicals Ltd herewith submit Compliance under Regulation 39(3)
Regulatory Filings
2020-07-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q4 FY 2020 earnings conference call of Bodal Chemicals Limited held on July 6, 2020. It includes management commentary on financial results, business strategy, market conditions, and a Q&A session with analysts. The text references quarterly financial results, discusses revenue, EBITDA, profit, production volumes, and business outlook. The presence of a full transcript of the earnings call with Q&A clearly identifies this as a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full text of the call, not just an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT) with high confidence.
2020-07-08 English
Bodal Chemicals Limited has informed the Exchange about Con. Call transcript of Q4FY20 Conference Call
Regulatory Filings
2020-07-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a Confirmation Certificate related to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2020. It is issued by the Registrar and Transfer Agent (Link Intime India Pvt Ltd) and submitted to stock exchanges (BSE and NSE). The content confirms processing of dematerialisation requests and related compliance, including delays due to COVID-19. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion. It is a regulatory filing confirming compliance with SEBI regulations, thus best classified under Regulatory Filings (RNS). The document length is under 5,000 characters, and it is a certificate, not a report or announcement of a report.
2020-07-08 English
Bodal Chemicals Ltd herewith inform stock Exchange about submission of Reg 74(5) of SEBI (DP) Regulation 2018
Regulatory Filings
2020-07-08 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the submission of newspaper advertisements for the audited standalone and consolidated financial results for the quarter and year ended 31-03-2020. It mentions that the financial results were approved by the Board of Directors on 06th July 2020 and published in newspapers on 07th July 2020. The document itself is not the financial report but an announcement of the publication of the audited financial results. It is a regulatory filing informing the exchanges about the advertisement of the financial results, not the full report or detailed financial statements. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to financial results publication.
2020-07-07 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.